Sheila Botts

755 total citations
22 papers, 552 citations indexed

About

Sheila Botts is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Pharmacology. According to data from OpenAlex, Sheila Botts has authored 22 papers receiving a total of 552 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Psychiatry and Mental health, 6 papers in Pediatrics, Perinatology and Child Health and 4 papers in Pharmacology. Recurrent topics in Sheila Botts's work include Schizophrenia research and treatment (12 papers), Bipolar Disorder and Treatment (5 papers) and Treatment of Major Depression (4 papers). Sheila Botts is often cited by papers focused on Schizophrenia research and treatment (12 papers), Bipolar Disorder and Treatment (5 papers) and Treatment of Major Depression (4 papers). Sheila Botts collaborates with scholars based in United States, Colombia and Taiwan. Sheila Botts's co-authors include José de León, Francisco J. Díaz, Margaret T. Susce, Edoardo Spina, Valentina Santoro, Douglas Steinke, Thomas Delate, Vincenza Santoro, Maria Rosaria Anna Muscatello and Meghan Morgan-Smith and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Journal of Clinical Psychiatry.

In The Last Decade

Sheila Botts

22 papers receiving 529 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sheila Botts United States 12 336 103 97 87 56 22 552
J Levine United States 14 379 1.1× 51 0.5× 198 2.0× 62 0.7× 39 0.7× 37 768
I. Kurzthaler Austria 15 462 1.4× 76 0.7× 97 1.0× 40 0.5× 39 0.7× 31 704
Corina Young United Kingdom 9 530 1.6× 59 0.6× 102 1.1× 33 0.4× 30 0.5× 11 630
Ellen M. Weissman United States 12 276 0.8× 48 0.5× 82 0.8× 38 0.4× 23 0.4× 20 506
Ann M. Hamer United States 6 193 0.6× 35 0.3× 47 0.5× 60 0.7× 29 0.5× 6 408
Hung‐Yu Chan Taiwan 17 443 1.3× 48 0.5× 168 1.7× 35 0.4× 60 1.1× 57 789
Mary Weber United States 11 387 1.2× 174 1.7× 131 1.4× 71 0.8× 27 0.5× 28 789
Jonathan T. Stewart United States 15 271 0.8× 49 0.5× 101 1.0× 40 0.5× 57 1.0× 64 649
Kajsa Kvist Denmark 17 210 0.6× 131 1.3× 132 1.4× 44 0.5× 46 0.8× 33 1.5k
Ann Hartry United States 15 488 1.5× 45 0.4× 126 1.3× 49 0.6× 27 0.5× 36 682

Countries citing papers authored by Sheila Botts

Since Specialization
Citations

This map shows the geographic impact of Sheila Botts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheila Botts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheila Botts more than expected).

Fields of papers citing papers by Sheila Botts

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheila Botts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheila Botts. The network helps show where Sheila Botts may publish in the future.

Co-authorship network of co-authors of Sheila Botts

This figure shows the co-authorship network connecting the top 25 collaborators of Sheila Botts. A scholar is included among the top collaborators of Sheila Botts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheila Botts. Sheila Botts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Glanz, Jason M., Shane R. Mueller, Komal J. Narwaney, et al.. (2024). Effectiveness of direct patient outreach with a narrative naloxone and overdose prevention video to patients prescribed long-term opioid therapy in the USA: the Naloxone Navigator randomised clinical trial. SHILAP Revista de lepidopterología. 2(1). e000725–e000725. 1 indexed citations
2.
Derington, Catherine G., Jordan B. King, Thomas Delate, et al.. (2020). Twice-daily versus once-daily lisinopril and losartan for hypertension: Real-world effectiveness and safety. PLoS ONE. 15(12). e0243371–e0243371. 1 indexed citations
3.
Heath, Lauren, et al.. (2018). Risk Factors for Utilization of Acute Care Services for Lithium Toxicity. Psychiatric Services. 69(6). 671–676. 4 indexed citations
4.
Nuffer, Wesley, Sheila Botts, Kari L. Franson, et al.. (2017). Curriculum renewal: Alignment of introductory pharmacy practice experiences with didactic course content. Currents in Pharmacy Teaching and Learning. 9(6). 1063–1070. 8 indexed citations
5.
Delate, Thomas, et al.. (2017). Metabolic monitoring in children 5 years of age and younger prescribed second-generation antipsychotic medications. Mental Health Clinician. 7(1). 1–6. 8 indexed citations
6.
Botts, Sheila, et al.. (2017). Design and implementation of population-based specialty care programs. American Journal of Health-System Pharmacy. 74(18). 1437–1445. 5 indexed citations
7.
Delate, Thomas, et al.. (2014). Metabolic Monitoring in Commercially Insured Pediatric Patients Newly Initiated to Take a Second-Generation Antipsychotic. JAMA Pediatrics. 168(7). 679–679. 23 indexed citations
8.
Díaz, Francisco J., et al.. (2009). Tobacco smoking behaviors in bipolar disorder: a comparison of the general population, schizophrenia, and major depression. Bipolar Disorders. 11(2). 154–165. 139 indexed citations
9.
Steinke, Douglas, et al.. (2009). Medication Adherence and Its Effect on Relapse Among Patients Discharged from a Veterans Affairs Posttraumatic Stress Disorder Treatment Program. Annals of Pharmacotherapy. 43(7-8). 1227–1232. 23 indexed citations
10.
11.
Botts, Sheila, Francisco J. Díaz, Vincenza Santoro, et al.. (2008). Estimating the effects of co-medications on plasma olanzapine concentrations by using a mixed model. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 32(6). 1453–1458. 39 indexed citations
12.
Botts, Sheila, et al.. (2005). High vulnerability to acute dystonic reactions: A case of antipsychotic exposure and uncontrolled seizure activity. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 29(5). 770–774. 5 indexed citations
13.
Botts, Sheila, et al.. (2004). Variables Associated With High Olanzapine Dosing in a State Hospital. The Journal of Clinical Psychiatry. 65(8). 1138–1143. 18 indexed citations
14.
Botts, Sheila, et al.. (2003). Datapoints: Antipsychotic Polypharmacy in the Ambulatory Care Setting, 1993-2000. Psychiatric Services. 54(8). 1086–1086. 28 indexed citations
15.
Botts, Sheila, et al.. (2001). Olanzapine-Induced Diabetes Mellitus. Annals of Pharmacotherapy. 35(5). 563–565. 41 indexed citations
16.
Botts, Sheila & Cara L. Alfaro. (2001). Antidepressant Drug Interactions. Journal of Pharmacy Practice. 14(6). 467–477. 3 indexed citations
17.
Botts, Sheila, et al.. (2001). Olanzapine-Induced Diabetes Mellitus. Annals of Pharmacotherapy. 35. 563–565. 3 indexed citations
18.
Botts, Sheila, et al.. (2000). Clozapine-Induced Hypersalivation. Annals of Pharmacotherapy. 34(5). 662–665. 58 indexed citations
19.
Botts, Sheila, et al.. (2000). Clozapine-Induced Hypersalivation. Annals of Pharmacotherapy. 34. 662–665. 4 indexed citations
20.
Botts, Sheila, et al.. (1999). Gabapentin and lamotrigine in bipolar disorder. American Journal of Health-System Pharmacy. 56(19). 1939–1944. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J Levine Breakdown of academic impact, for papers by I. Kurzthaler Breakdown of academic impact, for papers by Corina Young Breakdown of academic impact, for papers by Ellen M. Weissman Breakdown of academic impact, for papers by Ann M. Hamer Breakdown of academic impact, for papers by Hung‐Yu Chan Breakdown of academic impact, for papers by Mary Weber Breakdown of academic impact, for papers by Jonathan T. Stewart Breakdown of academic impact, for papers by Kajsa Kvist Breakdown of academic impact, for papers by Ann Hartry
Rankless by CCL
2026